Congratulations to our Scientific & Medical Advisory Board (SMAB) member and Research Acceleration Network (RAN) grantee Robert Vonderheide, MD, DPhil, for being named as the new director of the Abramson Cancer Center of the University of Pennsylvania.

Dr. Vonderheide is one of the foremost experts on translational research and cancer immunotherapy and has a fierce commitment to improving patient outcomes. We send our deepest appreciation for his continued efforts in accelerating research progress in the fight against pancreatic cancer.

Way to go, Dr. Vonderheide!